
Clockwise from left: Yangyang Yao, Navyateja Korimerla, Daniel Wahl, Hanshi Sun, Andrew Scott, Ayesha Kothari, Kari Romans, Christian Werner and Weihua Zhou
The overarching focus of the Wahl laboratory is to improve treatments for patients with glioblastoma, the most common and aggressive type of brain tumor. The group is especially interested in how abnormal metabolism confers radiation resistance in glioblastoma and using drug-radiation combinations to overcome this resistance.
Laboratory Lead

Lab Members









